{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T20:13:35Z","timestamp":1782504815823,"version":"3.54.5"},"reference-count":14,"publisher":"Impact Journals, LLC","issue":"33","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2016,8,16]]},"DOI":"10.18632\/oncotarget.10376","type":"journal-article","created":{"date-parts":[[2016,7,2]],"date-time":"2016-07-02T03:53:38Z","timestamp":1467431618000},"page":"52614-52617","source":"Crossref","is-referenced-by-count":10,"title":["CALR mutation characterization in myeloproliferative neoplasms"],"prefix":"10.18632","volume":"7","author":[{"given":"Cristina","family":"Bilbao-Sieyro","sequence":"first","affiliation":[{"name":"Hematology Department, Hospital Universitario de Gran Canaria Dr. Negrin, Las Palmas de Gran Canaria, Spain"},{"name":"Morfology Department, Universidad de Las Palmas de Gran Canaria, Las Palmas de Gran Canaria, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanira","family":"Florido","sequence":"additional","affiliation":[{"name":"Hematology Department, Hospital Universitario de Gran Canaria Dr. Negrin, Las Palmas de Gran Canaria, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Teresa","family":"G\u00f3mez-Casares","sequence":"additional","affiliation":[{"name":"Hematology Department, Hospital Universitario de Gran Canaria Dr. Negrin, Las Palmas de Gran Canaria, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2016,7,1]]},"reference":[{"key":"1","doi-asserted-by":"publisher","first-page":"2379","DOI":"10.1056\/NEJMoa1311347","article-title":"Somatic mutations of calreticulin in myeloproliferative neoplasms","volume":"369","author":"Bagienski","year":"2013","journal-title":"The New England journal of medicine"},{"key":"2","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.1038\/leu.2014.83","article-title":"Type 1 vs type 2 calreticulin mutations in primary myelofibrosis: differences in phenotype and prognostic impact","volume":"28","author":"Pardanani","year":"2014","journal-title":"Leukemia"},{"key":"3","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1182\/blood-2013-11-538983","article-title":"Impact of Calreticulin Mutations on Clinical and Hematological Phenotype and Outcome in Essential Thrombocythemia","volume":"123","author":"Vannucchi","year":"2014","journal-title":"Blood"},{"key":"4","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1182\/blood-2013-11-539098","article-title":"JAK2 or CALR mutation status defines subtypes of essential thrombocythemia with substantially different clinical course and outcomes","volume":"123","author":"Bellini","year":"2014","journal-title":"Blood"},{"key":"5","doi-asserted-by":"publisher","first-page":"2507","DOI":"10.1182\/blood-2014-05-579136","article-title":"Long-term survival and blast transformation in molecularly annotated essential thrombocythemia, polycythemia vera, and myelofibrosis","volume":"124","author":"Rambaldi","year":"2014","journal-title":"Blood"},{"key":"6","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1182\/blood-2014-05-578435","article-title":"Clinical effect of driver mutations of JAK2, CALR, or MPL in primary myelofibrosis","volume":"124","author":"Cavalloni","year":"2014","journal-title":"Blood"},{"key":"7","doi-asserted-by":"publisher","first-page":"2106","DOI":"10.1038\/leu.2014.190","article-title":"Bioinformatic analyses of CALR mutations in myeloproliferative neoplasms support a role in signaling","volume":"28","author":"Vizmanos","year":"2014","journal-title":"Leukemia"},{"key":"8","doi-asserted-by":"publisher","first-page":"e103511","DOI":"10.1371\/journal.pone.0103511","article-title":"High resolution melting analysis: a rapid and accurate method to detect CALR mutations","volume":"9","author":"Gomez-Casares","year":"2014","journal-title":"PloS one"},{"key":"9","doi-asserted-by":"publisher","first-page":"2465","DOI":"10.1182\/blood-2014-07-588426","article-title":"The prognostic advantage of calreticulin mutations in myelofibrosis might be confined to type 1 or type 1-like CALR variants","volume":"124","author":"Pardanani","year":"2014","journal-title":"Blood"},{"key":"10","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1038\/leu.2015.277","article-title":"Differential clinical effects of different mutation subtypes in CALR-mutant myeloproliferative neoplasms","volume":"30","author":"Roncoroni","year":"2016","journal-title":"Leukemia"},{"key":"11","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.leukres.2014.11.019","article-title":"Evaluation of methods to detect CALR mutations in myeloproliferative neoplasms","volume":"39","author":"Cross","year":"2015","journal-title":"Leukemia research"},{"key":"12","doi-asserted-by":"publisher","first-page":"e295","DOI":"10.1038\/bcj.2015.21","article-title":"Frequent CALR exon 9 alterations in JAK2 V617F- mutated essential thrombocythemia detected by high-resolution melting analysis","volume":"5","author":"Kuo","year":"2015","journal-title":"Blood cancer journal"},{"key":"13","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1182\/blood-2015-09-671172","article-title":"Activation of the thrombopoietin receptor by mutant calreticulin in CALR-mutant myeloproliferative neoplasms","volume":"127","author":"Komatsu","year":"2016","journal-title":"Blood"},{"key":"14","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1158\/2159-8290.cd-15-1434","article-title":"Mutant Calreticulin Requires Both Its Mutant C-terminus and the Thrombopoietin Receptor for Oncogenic Transformation","volume":"6","author":"Losman","year":"2016","journal-title":"Cancer discovery"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.10376","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,12]],"date-time":"2020-05-12T09:58:40Z","timestamp":1589277520000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.10376"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7,1]]},"references-count":14,"journal-issue":{"issue":"33","published-print":{"date-parts":[[2016,8,16]]}},"alternative-id":["10376","27384487"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.10376","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,7,1]]}}}